Sec Form 4 Filing - Hertzberg Richard @ Cellectar Biosciences, Inc. - 2016-08-09

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Hertzberg Richard 2. Issuer Name and Ticker or Trading Symbol Cellectar Biosciences, Inc. [ clrB] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) X __ Other (specify below) significant owner (Last) (First) (Middle) 1329 STRATFORD COURT 3. Date of Earliest Transaction (MM/DD/YY) 08/09/2016 (Street) DEL MAR, CA92014 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Cellectar Biosciences, Inc. common stock (CLRB) ( 1 ) 10/31/2016 10/31/2016 S V 21,000 D $ 2.029 280,000 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Cellectar Biosciences Inc. Warrant (CLRBW) ( 2 ) $ 46.8 08/09/2016 S V 40,916 08/21/2014 08/20/2019 Cellectar Biosciences, Inc. common stock (CLRB) 40,916 $ 1.75 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Hertzberg Richard 1329 STRATFORD COURT DEL MAR, CA92014 significant owner Signatures Richard Hertzberg 11/01/2016 Signature of Reporting Person Date

Explanation of Responses:

( 1 )CLRB stock sales during period October 13 through October 31, 2016 ( 2 )Price of CLRB at close of market 11/1/2016

Remarks: Total CLRB beneficial ownership percentage of Hertzberg at 10/31/2016 based upon 5,368,235 total outstanding shares of CLRB reported by company as of 10/31/2016 is five and two/tenths percent (5.2%).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.